SCHEMBL5651101

SCHEMBL5651101

c1ccc(-c2nnnn2CN2CCOCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.54
▸ ALDH1A1 P00352 5/20 0.50
▸ POLB P06746 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ LMNA P02545 2/20 0.48
▸ THRB P10828 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ P2RX7 Q99572 3/20 0.47
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A4 P31645 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ HSD11B1 P28845 1/20 0.45
▸ TSHR P16473 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ DRD4 P21917 1/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ CHRM1 P11229 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5651575 0.89 ALDH1A1 (0.57) ALDH1A1POLBHTTLMNAP2RX7
SCHEMBL5651027 0.82 ALDH1A1 (0.50) ALDH1A1POLBHTTLMNAP2RX7
SCHEMBL5654716 0.82 ALDH1A1 (0.54) ALDH1A1POLBHTTP2RX7SLC6A2
SCHEMBL5654689 0.82 ALDH1A1 (0.50) ALDH1A1POLBHTTLMNAP2RX7
SCHEMBL5651024 0.79 ALDH1A1 (0.47) ALDH1A1POLBHTTLMNATHRB
SCHEMBL12761225 0.71 ALDH1A1 (0.62) ALDH1A1POLBHTTLMNAP2RX7
SCHEMBL1154434 0.71 ALDH1A1 (0.62) ALDH1A1POLBHTTLMNAP2RX7
SCHEMBL5651126 0.71 ALDH1A1 (0.62) ALDH1A1POLBHTTLMNAP2RX7
SCHEMBL2491350 0.70 CYP2D6 (1.00) CYP2D6ALDH1A1HTTLMNATHRB
SCHEMBL4403732 0.69 P2RX7 (0.81) ALDH1A1POLBHTTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161691-A1 Modified-protein formation inhibitor TOKAI UNIVERSITY (JP) 2007-07-12 — — US disclosed
US-20070161691-A1 Modified-protein formation inhibitor TOKAI UNIVERSITY (JP) 2007-07-12 — — US disclosed
US-20070161691-A1 Modified-protein formation inhibitor TOKAI UNIVERSITY (JP) 2007-07-12 — — US disclosed
EP-1690857-A1 MODIFIED-PROTEIN FORMATION INHIBITOR TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2006-08-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161691-A1 Modified-protein formation inhibitor PTMS, ALB, AGER CYP2D6 4178/4885ALDH1A1 3045/4885POLB 4309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback